Report of the Signal Transduction Society Meeting 2017—Metabolism in Health and Disease

The annual “Joint Meeting Signal Transduction—Receptors, Mediators and Genes” of the Signal Transduction Society (STS) aims to be an interdisciplinary forum for researchers who share a common interest in deciphering signal transduction pathways in normal or transformed cells, in health and disease, in humans and animal models, or in plants or bacteria. The special focus of the 21st annual Joint Meeting, which took place from 8–10 November 2017 in Weimar, was the topic “Metabolism in Health and Disease” and covered multiple aspects of this highly exciting and fast developing research field. Invited keynote speakers introduced the impact of metabolism on tumor immunology, immune cell signaling, and posttranslational modifications in three specific workshops to the audience. Various other aspects of signal transduction were intensively discussed in five additional workshops. Here, we give an overview of the various workshops and further aspects of the scientific program.

[1]  C. Akdis,et al.  Microbiome and asthma , 2018, Asthma Research and Practice.

[2]  K. Garcia,et al.  Ligand-induced type II interleukin-4 receptor dimers are sustained by rapid re-association within plasma membrane microcompartments , 2017, Nature Communications.

[3]  C. Stallings,et al.  Host response: Inflammation promotes TB growth , 2017, Nature Microbiology.

[4]  T. Mak,et al.  Glutathione Primes T Cell Metabolism for Inflammation , 2017, Immunity.

[5]  M. Gold,et al.  The Rap1–cofilin-1 pathway coordinates actin reorganization and MTOC polarization at the B cell immune synapse , 2017, Journal of Cell Science.

[6]  P. Hellings,et al.  A wide diversity of bacteria from the human gut produces and degrades biogenic amines , 2017, Microbial ecology in health and disease.

[7]  G. Hart,et al.  Roles of O-GlcNAc in chronic diseases of aging. , 2016, Molecular aspects of medicine.

[8]  T. Sparwasser,et al.  Metabolic pathways in T cell activation and lineage differentiation. , 2016, Seminars in immunology.

[9]  A. Schulze,et al.  The multifaceted roles of fatty acid synthesis in cancer , 2016, Nature Reviews Cancer.

[10]  T. Sparwasser,et al.  Disruption of de novo fatty acid synthesis via acetyl‐CoA carboxylase 1 inhibition prevents acute graft‐versus‐host disease , 2016, European journal of immunology.

[11]  G. Hart,et al.  New insights: A role for O-GlcNAcylation in diabetic complications , 2016, Critical reviews in biochemistry and molecular biology.

[12]  M. Reth,et al.  The nanoscale organization of the B lymphocyte membrane☆ , 2015, Biochimica et biophysica acta.

[13]  K. David,et al.  Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma , 2013, International journal of cancer.

[14]  Michael Reth,et al.  Matching cellular dimensions with molecular sizes , 2013, Nature Immunology.

[15]  M. Reth,et al.  Synthetic immune signaling. , 2012, Current opinion in biotechnology.

[16]  R. Deberardinis,et al.  Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? , 2012, Cell.

[17]  D. Scott,et al.  Immunoreceptor tyrosine-based activation motif is required to signal pathways of receptor-mediated growth arrest and apoptosis in murine B lymphoma cells. , 1995, Journal of immunology.

[18]  A. Schulze,et al.  The Role of Glucose and Lipid Metabolism in Growth and Survival of Cancer Cells. , 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[19]  Gerald W. Hart,et al.  The O-GlcNAc Modification , 2009 .

[20]  U. Schumacher,et al.  Universitätsklinikum Hamburg-Eppendorf , 2006 .

[21]  S. Grinstein,et al.  Toll-like receptor ligands sensitize B-cell receptor signalling by reducing actin-dependent spatial confinement of the receptor , 2015, Nature Communications.